Home › Castration-Resistant Prostatic Cancer › Florida
Pag-aaral pangklinika para sa Castration-Resistant Prostatic Cancer sa Florida
5 pag-aaral para sa Castration-Resistant Prostatic Cancer ang naghahanap ng mga kalahok sa mga site sa Florida.
Opisyal na teksto ng pag-aaral (English)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- AdventHealth Orlando, Orlando
- Florida Cancer Specialists, Sarasota
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Bay Pines VA Healthcare System, Bay Pines
- Florida Cancer Specialists & Research Institute, Fort Myers
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 25, 2026 · NCT07164443Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
- University of Miami Hospital and Clinics, Sylvester Cancer Center-Cancer Research Services ( Site 0051), Miami
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06353386Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Mayo Clinic, Jacksonville
Nagre-recruitPhase 1
Edad 18 hanggang 100 · Kalalakihan · Na-update Ago 13, 2026 · NCT05519449A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Florida Cancer Specialists Sarasota Drug Development Unit, Sarasota
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Ago 10, 2026 · NCT06067841Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.